Compounds > glutamic acid

glutamic acid and Autosomal Dominant Cerebellar Ataxia, Type II

glutamic acid has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (53.85)	29.6817
2010's	6 (46.15)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bushara, KO; Deelchand, DK; Eberly, LE; Emir, UE; Gomez, CM; Hutter, D; Joers, JM; Lyu, T; Öz, G	1
Chen, SH; Chuang, CY; Huang, HP; Kuo, HC; Soong, BW; Yang, CC; Yu, CY	1
Adanyeguh, IM; Brice, A; Deelchand, DK; Durr, A; Eberly, LE; Emir, UE; Henry, PG; Jauffret, C; Mochel, F; Nguyen, TM; Öz, G; Rinaldi, D; Valabregue, R	1
Brandt, AU; Doss, S; Endres, M; Klockgether, T; Lux, S; Maul, S; Minnerop, M; Papazoglou, S; Paul, F; Rinnenthal, JL; Schmitz-Hübsch, T; Würfel, J	1
Hsieh-Li, HM; Huang, DS; Lee-Chen, GJ; Lin, HY; Lin, JY; Wu, CH	1
Brusco, A; Cagnoli, C; Di Bella, D; Di Donato, S; Gellera, C; Mariotti, C; Seri, M; Taroni, F	1
Bezprozvanny, I; Herndon, E; Huynh, DP; Liu, J; Nelson, O; Pulst, SM; Tang, TS; Tu, H	1
van de Warrenburg, BP; Verbeek, DS	1
König, T; Möck, M; Sultan, F; Thier, P	1
Byam, CE; Lande, JD; Orr, HT; Serra, HG; Tousey, SK; Zoghbi, HY	1
Dalski, A; Finckh, U; Schwinger, E; Zühlke, C	1
Bassi, MT; Bresolin, N; D'Angelo, MG; Frattini, T; Germinasi, C; Meola, G; Salati, R; Tonelli, A; Turconi, AC; Villa, L	1
Kremer, BP; Rabelink, GM; Sinke, RJ; van de Warrenburg, BP; Vlak, MH	1

Reviews

1 review(s) available for glutamic acid and Autosomal Dominant Cerebellar Ataxia, Type II

Article	Year
Genetics of the dominant ataxias. Seminars in neurology, 2011, Volume: 31, Issue:5 Topics: Genes, Dominant; Genetic Association Studies; Glutamic Acid; Humans; Mutation; Peptides; Phenotype; Spinocerebellar Ataxias; Transcription, Genetic; Trinucleotide Repeat Expansion	2011

Other Studies

12 other study(ies) available for glutamic acid and Autosomal Dominant Cerebellar Ataxia, Type II

Article	Year
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias. Annals of neurology, 2018, Volume: 83, Issue:4 Topics: Activities of Daily Living; Adult; Aged; Aspartic Acid; Ataxins; Brain; Brain Diseases, Metabolic; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Spinocerebellar Ataxias; Young Adult	2018
Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology. Scientific reports, 2019, 02-04, Volume: 9, Issue:1 Topics: Cell Survival; Cells, Cultured; Glutamic Acid; Humans; Induced Pluripotent Stem Cells; Models, Theoretical; Neurons; Spinocerebellar Ataxias	2019
In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Movement disorders : official journal of the Movement Disorder Society, 2015, Apr-15, Volume: 30, Issue:5 Topics: Adult; Aspartic Acid; Ataxins; Cohort Studies; Female; Glutamic Acid; Humans; Machado-Joseph Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Principal Component Analysis; Protons; Spinocerebellar Ataxias; Statistics as Topic	2015
Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency. Journal of neurology, 2015, Volume: 262, Issue:8 Topics: Adult; Aged; Aspartic Acid; Cerebellum; Cerebral Cortex; Creatine; Female; Glutamic Acid; Glutathione; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Spinocerebellar Ataxias	2015
Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17. Drug design, development and therapy, 2016, Volume: 10 Topics: Animals; Apoptosis; Calcium; Cell Line, Tumor; Disease Models, Animal; Ginkgo biloba; Glutamic Acid; Humans; Mice; Mice, Transgenic; Plant Extracts; Spinocerebellar Ataxias	2016
Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis. Cerebellum (London, England), 2008, Volume: 7, Issue:2 Topics: Adolescent; Adult; Aged; Base Sequence; Brain; Child; Chromosome Mapping; Chromosomes, Human, Pair 18; Female; Genes, Dominant; Glutamic Acid; Humans; Lysine; Magnetic Resonance Imaging; Male; Middle Aged; Ophthalmoplegia; Pedigree; Phenotype; Point Mutation; Polymorphism, Single Nucleotide; Spinocerebellar Ataxias; Young Adult	2008
Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jul-22, Volume: 29, Issue:29 Topics: Animals; Ataxins; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dantrolene; Excitatory Amino Acid Agents; Glutamic Acid; Glycine; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Transgenic; Motor Activity; Nerve Degeneration; Nerve Tissue Proteins; Purkinje Cells; Resorcinols; Ryanodine; Spinocerebellar Ataxias	2009
Quantitative organization of neurotransmitters in the deep cerebellar nuclei of the Lurcher mutant. The Journal of comparative neurology, 2002, Oct-28, Volume: 452, Issue:4 Topics: Animals; Cell Count; Cerebellar Nuclei; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Immunohistochemistry; Mice; Mice, Neurologic Mutants; Neural Inhibition; Neurons; Neurotransmitter Agents; Presynaptic Terminals; Spinocerebellar Ataxias	2002
Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Human molecular genetics, 2004, Oct-15, Volume: 13, Issue:20 Topics: Animals; Ataxin-1; Ataxins; Carrier Proteins; Gene Expression; Gene Expression Profiling; Glutamic Acid; Homer Scaffolding Proteins; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Protein Isoforms; Purkinje Cells; Repetitive Sequences, Amino Acid; RNA, Messenger; Signal Transduction; Spinocerebellar Ataxias	2004
Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes. BMC medical genetics, 2005, Jul-01, Volume: 6 Topics: Adult; Adult Children; Aged; Alleles; Female; Founder Effect; Gene Frequency; Genotype; Glutamic Acid; Haplotypes; Humans; Male; Middle Aged; Pedigree; Penetrance; Phenotype; Spinocerebellar Ataxias; Spinocerebellar Degenerations; TATA-Box Binding Protein	2005
Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene. Journal of the neurological sciences, 2006, Feb-15, Volume: 241, Issue:1-2 Topics: Age of Onset; Arginine; Calcium Channels; Child, Preschool; DNA Mutational Analysis; Glutamic Acid; Humans; Male; Mutation, Missense; Spinocerebellar Ataxias	2006
Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Atrophy; Basal Ganglia Diseases; Cerebellum; DNA Mutational Analysis; Exons; Female; Glutamic Acid; Humans; Isoenzymes; Magnetic Resonance Imaging; Male; Middle Aged; Mutation, Missense; Myoclonus; Netherlands; Pedigree; Phenotype; Protein Kinase C; Spinocerebellar Ataxias; Tremor; Valine	2006